Clinical Trial Update: Effect of Thrombin-containing Collagen-based Hemostatic Matrix [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a thrombin-containing collagen-based hemostatic matrix in pancreatic tumor patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Tumor

Snippet

Sponsor: Asan Medical Center | Conditions: Pancreatic Tumor | Phase 4 | Status: UNKNOWN